An activating mutation of the NSD2 histone methyltransferase drives oncogenic reprogramming in acute lymphocytic leukemia-Reference-Cited by-同舟云学术

An activating mutation of the NSD2 histone methyltransferase drives oncogenic reprogramming in acute lymphocytic leukemia

Published:2018-08-31 Issue:5 Volume:38 Page:671-686
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Swaroop Alok,Oyer Jon A.,Will Christine M.,Huang Xiaoxiao,Yu Wenbo,Troche Catalina,Bulic Marinka,Durham Benjamin H.,Wen Qiang Jeremy,Crispino John D.,MacKerell Alexander D.,Bennett Richard L.,Kelleher Neil L.^ORCID,Licht Jonathan D.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/s41388-018-0474-y.pdf

Reference70 articles.

1. Society AC. Cancer facts & figures 2014. Atlanta: American Cancer Society; 2014.

2. Golub TR. Genomics: global views of leukaemia. Nature. 2007;446:739–40.

3. Society AC. Cancer facts & figures 2016. Atlanta: American Cancer Society; 2016.

4. Mullighan CG. Genome sequencing of lymphoid malignancies. Blood. 2013;122:3899–907.

5. Beà S, Valdés-Mas R, Navarro A, Salaverria I, Martín-Garcia D, Jares P, et al. Landscape of somatic mutations and clonal evolution in mantle cell lymphoma. Proc Natl Acad Sci USA. 2013;110:18250–5.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recruitment of FBXO22 for targeted degradation of NSD2;Nature Chemical Biology;2024-07-04

2. Intestinal NSD2 Aggravates Nonalcoholic Steatohepatitis Through Histone Modifications;Advanced Science;2024-06-26

3. Discovery of LLC0424 as a Potent and Selective in Vivo NSD2 PROTAC Degrader;Journal of Medicinal Chemistry;2024-04-30

4. NSD family proteins: Rising stars as therapeutic targets;Cell Insight;2024-04

5. Recruitment of FBXO22 for Targeted Degradation of NSD2;2023-11-02